548 filings
Page 5 of 28
SD
mrese6
21 May 20
Conflict minerals disclosure
4:45pm
8-K
qw0 csoa3s
12 May 20
Other Events
6:23am
8-K
21pwrs0t8z7a18
30 Apr 20
Abiomed Announces Q4 Fy 2020 Revenue of $207 Million and 28.1% Operating Margin
7:38am
8-K
mm0nf45fi1nr11
6 Feb 20
Abiomed Announces Q3 Fy 2020 Revenue of $222 Million and 31.7% Operating Margin
7:26am
8-K
2z7zosb
13 Jan 20
Abiomed Announces Preliminary Q3 Fy 2020 Revenue of $222 Million, Up 10% Over Prior Year
8:38am
8-K
6n3919v ra524gn5lcj5
31 Oct 19
Abiomed Announces Q2 Fy 2020 Revenue of $205 Million and 29.4% Operating Margin
7:14am
8-K
clol2vpb
9 Aug 19
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
tjh jlzkjp5i6vw11
5 Aug 19
Other Events
6:44am
8-K
4sziw lsy
1 Aug 19
Abiomed Announces Q1 Fy 2020 Revenue of $208 Million and 29.2% Operating Margin
7:18am
DEFA14A
5ahxwd yx7c052
25 Jun 19
Additional proxy soliciting materials
9:09am
8-K
da8l31d9x1p6s395e0bk
3 Jun 19
Departure of Directors or Certain Officers
4:10pm
SD
9fuj0j yns
23 May 19
Conflict minerals disclosure
4:15pm
8-K
tr27vbwv
2 May 19
Abiomed Announced Q4 Fy 2019 Revenue of $207 Million and 31.6% Operating Margin
7:14am